StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) stock

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

AstraZeneca's enterprise value was $536.85B on Oct 19, 2026, against $539.40B a year earlier. Over the last 5 years it ranged from $141.10B to $673.77B, with a median of $469.54B.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026$536.85B-10.4%
2025Dec 31, 2025$598.99B+37.8%
2024Dec 31, 2024$434.83B-2.0%
2023Dec 29, 2023$443.51B+8.0%
2022Dec 30, 2022$410.83B+180.2%
2017Jan 31, 2017$146.62B-0.3%
2016Dec 30, 2016$147.07B–

More AstraZeneca figures

See a number that looks wrong?